1. Assessment of the circulating klotho protein in lung cancer patients
   Judit Pako et al, 2020, Pathology & Oncology Research CrossRef
2. Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
   Valentine M. Macaulay et al, 2016, Clinical Cancer Research CrossRef
3. S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
   Hua Shen et al, 2020, Oncogene CrossRef
4. The Links Between Insulin Resistance, Diabetes, and Cancer
   Etan Orgel et al, 2013, Current Diabetes Reports CrossRef
5. Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
   Mónica Enguita-Germán, 2014, World Journal of Hepatology CrossRef
6. Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
   Philip A. Philip et al, 2014, Cancer CrossRef
7. Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
   Sahitya K. Denduluri et al, 2015, Genes & Diseases CrossRef
8. Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity
   Mengting Shao et al, 2022, Molecules CrossRef
9. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells
   Jung-Min Choi et al, 2015, Lung Cancer CrossRef
10. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
    Alexander W. Pohlman et al, 2022, Oncotarget CrossRef
11. Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors
    Fariz Nurwidya et al, 2014, Respiratory Investigation CrossRef
12. Antiproliferative, Cell-Cycle Dysregulation Effects of Novel Asiatic Acid Derivatives on Human Non-small Cell Lung Cancer Cells
    Liang Wang et al, 2013, Chemical and Pharmaceutical Bulletin CrossRef
13. Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer
    Alina Proske et al, 2021, Aging CrossRef